An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes
Failure to take medication reduces the effectiveness of treatment leading to increased morbidity and mortality. We evaluated the efficacy of a consultation-based intervention to support objectively-assessed adherence to oral glucose lowering medication (OGLM) compared to usual care among people with type 2 diabetes.
This was a parallel group randomised trial in adult patients with type 2 diabetes and HbA1c≥7.5% (58 mmol/mol), prescribed at least one OGLM. Participants were allocated to a clinic nurse delivered, innovative consultation-based intervention to strengthen patient motivation to take OGLM regularly and support medicine taking through action-plans, or to usual care. The primary outcome was the percentage of days on which the prescribed dose of medication was taken, measured objectively over 12 weeks with an electronic medication-monitoring device (TrackCap, Aardex, Switzerland). The primary analysis was intention-to-treat.
211 patients were randomised between July 1, 2006 and November 30, 2008 in 13 British general practices (primary care clinics). Primary outcome data were available for 194 participants (91.9%). Mean (sd) percentage of adherent days was 77.4% (26.3) in the intervention group and 69.0% (30.8) in standard care (mean difference between groups 8.4%, 95% confidence interval 0.2% to 16.7%, p = 0.044). There was no significant adverse impact on functional status or treatment satisfaction.
This well-specified, theory based intervention delivered in a single session of 30 min in primary care increased objectively measured medication adherence, with no adverse effect on treatment satisfaction. These findings justify a definitive trial of this approach to improving medication adherence over a longer period of time, with clinical and cost-effectiveness outcomes to inform clinical practice.
Current Controlled Trials ISRCTN30522359
- World Health Organization: Adherence to long-term therapies: evidence for action. Geneva: World Health Organisation; 2003.
- Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O: Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. N Engl J Med 2003,348(5):383–93. CrossRef
- Hertz RP, Unger AN, Lustik MB: Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 2005,27(7):1064–73. CrossRef
- Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC: Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 2009,15(6):e22–33.
- Cramer JA: A Systematic Review of Adherence With Medications for Diabetes. Diabetes Care 2004,27(5):1218–24. CrossRef
- Salas M, Hughes D, Zuluaga A, Vardeva K, Lebmeier M: Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health 2009,12(6):915–22. CrossRef
- Ho PM, Bryson CL, Rumsfeld JS: Medication adherence: its importance in cardiovascular outcomes. Circulation 2009,119(23):3028–35. CrossRef
- Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008,2(2):CD000011.
- Barber N: Should we consider non-compliance a medical error? Qual Saf Health Care 2002,11(1):81–4. CrossRef
- Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ, et al.: Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract 2008, 9:20. CrossRef
- Ajzen I: The theory of planned behaviour. Organ Behav Hum Decis Process 1991, 50:179–211. CrossRef
- Gollwitzer PM: Implementation intentions: strong effects of simple plans. Am Psychol 1999, 54:493–503. CrossRef
- Vrijens B, Goetghebeur E: The impact of compliance in pharmacokinetic studies. Stat Meth Med Res 1999, 8:247–62. CrossRef
- Ware J, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996,34(0025–7079; 3):220–33. CrossRef
- Lewis KS, Jennings AM, Ward JD, Bradley C: Health belief scales developed specifically for people with tablet-treated type 2 diabetes. Diabet Med 1990, 7:148–55. CrossRef
- Horne R, Weinman J: Predicting treatment adherence: an overview of theoretical models. In Adherence to treatment in medical conditions. Edited by: Myers L, Midence K. Harwood Academic, London, UK; 1998:25–50.
- Farmer A, Kinmonth AL, Sutton S: Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Diabet Med 2006,23(3):265–70. CrossRef
- White IR, Thompson SG: Adjusting for partially missing baseline measurements in randomized trials. Stat Med 2005,24(0277–6715; 7):993–1007. CrossRef
- Kripalani S, Yao X, Haynes RB: Interventions to Enhance Medication Adherence in Chronic Medical Conditions: A Systematic Review. Arch Intern Med 2007,167(6):540–9. CrossRef
- Frolkis JP, Pearce GL, Nambi V, Minor S, Sprecher DL: Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med 2002,113(8):625–9. CrossRef
- Pablos-Mendez A, Barr RG, Shea S: Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998,279(3):222–5. CrossRef
- Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, et al.: Discontinuation of antihyperlipidemic drugs–do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995,332(17):1125–31. CrossRef
- DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW: Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002,40(9):794–811. CrossRef
- McDonald HP, Garg AX, Haynes RB: Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review. JAMA 2002,288(22):2868–679. CrossRef
- Hardeman W, Sutton S, Griffin S, Johnston M, White AJ, Wareham NJ, et al.: A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Health Educ Res 2005,20(6):676–87. CrossRef
- Benson J, Britten N: Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ 2002,325(7369):873. CrossRef
- Byrne M, Walsh J, Murphy AW: Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res 2005, 58:403–15. CrossRef
- Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL: Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med 1997, 103:491–7. CrossRef
- Grant PJ: The effects of high and medium dose metformin therapy on cardiovascular risk factors in patients with type II diabetes. Diabetes Care 1996, 19:64–6. CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2296/13/30/prepub
- An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
BMC Family Practice
- Online Date
- April 2012
- Online ISSN
- BioMed Central
- Additional Links
- Brief intervention
- Author Affiliations
- 1. Department of Primary Health Care Sciences, University of Oxford, Oxford, UK
- 2. General Practice and Primary Care Research Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK
- 3. Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
- 4. Department of Primary Care and Public Health Sciences, King’s College London, London, UK
- 5. MRC Clinical Epidemiology Unit, Cambridge, UK